M. Mohammad Alabdali, “Direct Comparison of Treatment Outcome Between the Botulinum Toxin and Calcitonin Gene-Related Peptide Monoclonal Antibody in Migraine Patients”, J Clin Med Res, vol. 16, no. 11, pp. 527–535, Nov. 2024, doi: 10.14740/jocmr6054.